{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Défibrillation : Questions médicales les plus fréquentes",
"headline": "Défibrillation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Défibrillation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-04",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Défibrillation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Défibrillation",
"alternateName": "Electric Countershock",
"code": {
"@type": "MedicalCode",
"code": "D004554",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sam J England",
"url": "https://questionsmedicales.fr/author/Sam%20J%20England",
"affiliation": {
"@type": "Organization",
"name": "School of Biological Sciences, University of Bristol, Bristol, UK."
}
},
{
"@type": "Person",
"name": "Daniel Robert",
"url": "https://questionsmedicales.fr/author/Daniel%20Robert",
"affiliation": {
"@type": "Organization",
"name": "School of Biological Sciences, University of Bristol, Bristol, UK."
}
},
{
"@type": "Person",
"name": "Dorin Panescu",
"url": "https://questionsmedicales.fr/author/Dorin%20Panescu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hyeon Seo",
"url": "https://questionsmedicales.fr/author/Hyeon%20Seo",
"affiliation": {
"@type": "Organization",
"name": "School of Electrical Engineering and Computer Science, Gwangju Institute of Science & Technology, South Korea."
}
},
{
"@type": "Person",
"name": "Sung Chan Jun",
"url": "https://questionsmedicales.fr/author/Sung%20Chan%20Jun",
"affiliation": {
"@type": "Organization",
"name": "School of Electrical Engineering and Computer Science, Gwangju Institute of Science & Technology, South Korea. Electronic address: scjun@gist.ac.kr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39273131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36163292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.disamonth.2022.101468"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2022.09.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35931315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36082759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000000904"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Défibrillation",
"item": "https://questionsmedicales.fr/mesh/D004554"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Défibrillation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Défibrillation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Défibrillation",
"description": "Comment diagnostiquer une arythmie nécessitant une défibrillation ?\nQuels signes indiquent une nécessité de défibrillation ?\nQuel est le rôle de l'ECG dans la défibrillation ?\nPeut-on utiliser un défibrillateur sans diagnostic préalable ?\nQuels tests précèdent souvent la défibrillation ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Défibrillation",
"description": "Quels symptômes précèdent une défibrillation ?\nComment se manifeste une fibrillation ventriculaire ?\nQuels signes vitaux sont affectés avant une défibrillation ?\nQuels symptômes peuvent alerter sur un besoin de défibrillation ?\nQuels symptômes sont typiques d'un arrêt cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Défibrillation",
"description": "Comment prévenir les arythmies cardiaques ?\nQuels examens réguliers aident à prévenir les problèmes cardiaques ?\nComment l'éducation peut-elle prévenir les urgences cardiaques ?\nQuels médicaments peuvent prévenir les arythmies ?\nQuel rôle joue la gestion du stress dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Défibrillation",
"description": "Comment se déroule une défibrillation ?\nQuels appareils sont utilisés pour la défibrillation ?\nQuelle est l'efficacité de la défibrillation ?\nQuand doit-on administrer une défibrillation ?\nQuelles sont les étapes après une défibrillation ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Défibrillation",
"description": "Quelles complications peuvent survenir après une défibrillation ?\nComment les arythmies peuvent-elles évoluer après une défibrillation ?\nQuels sont les risques de lésions cardiaques ?\nQuelles sont les conséquences d'une défibrillation tardive ?\nQuels effets secondaires peuvent survenir après une défibrillation ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Défibrillation",
"description": "Quels facteurs augmentent le risque d'arythmies ?\nComment le tabagisme influence-t-il le risque cardiaque ?\nQuel rôle joue l'âge dans le risque d'arythmies ?\nComment l'obésité affecte-t-elle le cœur ?\nQuels médicaments peuvent augmenter le risque d'arythmies ?",
"url": "https://questionsmedicales.fr/mesh/D004554?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une arythmie nécessitant une défibrillation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un ECG est utilisé pour identifier les arythmies comme la fibrillation ventriculaire."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une nécessité de défibrillation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Perte de conscience, absence de pouls et respiration anormale sont des signes clés."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de l'ECG dans la défibrillation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ECG permet de visualiser le rythme cardiaque et de décider de l'urgence de la défibrillation."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser un défibrillateur sans diagnostic préalable ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas d'arrêt cardiaque, le défibrillateur peut être utilisé sans diagnostic préalable."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent souvent la défibrillation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'ECG et l'évaluation clinique précèdent souvent la défibrillation."
}
},
{
"@type": "Question",
"name": "Quels symptômes précèdent une défibrillation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des palpitations, des douleurs thoraciques et des étourdissements."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une fibrillation ventriculaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une perte de conscience rapide et une absence de pouls palpable."
}
},
{
"@type": "Question",
"name": "Quels signes vitaux sont affectés avant une défibrillation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fréquence cardiaque et la pression artérielle chutent, indiquant une urgence."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter sur un besoin de défibrillation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des évanouissements ou une respiration anormale peuvent alerter."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont typiques d'un arrêt cardiaque ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'absence de conscience, de respiration et de pouls."
}
},
{
"@type": "Question",
"name": "Comment prévenir les arythmies cardiaques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, aide à prévenir."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers aident à prévenir les problèmes cardiaques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cardiaques réguliers, comme des ECG, aident à détecter les problèmes précocement."
}
},
{
"@type": "Question",
"name": "Comment l'éducation peut-elle prévenir les urgences cardiaques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les signes d'alerte et l'utilisation des DEA peut sauver des vies."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent prévenir les arythmies ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antiarythmiques peuvent être prescrits pour prévenir les arythmies."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la gestion du stress dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress peut réduire le risque d'arythmies et d'autres problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Comment se déroule une défibrillation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La défibrillation délivre un choc électrique pour rétablir un rythme cardiaque normal."
}
},
{
"@type": "Question",
"name": "Quels appareils sont utilisés pour la défibrillation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les défibrillateurs externes automatisés (DEA) et les défibrillateurs manuels sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'efficacité de la défibrillation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La défibrillation est très efficace pour traiter la fibrillation ventriculaire et le pouls absent."
}
},
{
"@type": "Question",
"name": "Quand doit-on administrer une défibrillation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle doit être administrée immédiatement en cas d'arrêt cardiaque ou de fibrillation."
}
},
{
"@type": "Question",
"name": "Quelles sont les étapes après une défibrillation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après la défibrillation, il faut surveiller le patient et administrer des soins avancés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une défibrillation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des brûlures cutanées, des arythmies et des lésions cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les arythmies peuvent-elles évoluer après une défibrillation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines arythmies peuvent persister ou réapparaître après la défibrillation initiale."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de lésions cardiaques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chocs répétés peuvent entraîner des lésions myocardiques ou des troubles du rythme."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une défibrillation tardive ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une défibrillation tardive peut augmenter le risque de lésions cérébrales et de décès."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir après une défibrillation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires peuvent inclure des douleurs thoraciques et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'arythmies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension, le diabète et les antécédents familiaux augmentent le risque d'arythmies."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il le risque cardiaque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque d'arythmies et de maladies cardiaques en général."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'âge dans le risque d'arythmies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque d'arythmies augmente avec l'âge en raison de la dégradation des tissus cardiaques."
}
},
{
"@type": "Question",
"name": "Comment l'obésité affecte-t-elle le cœur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité augmente le risque d'arythmies et de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent augmenter le risque d'arythmies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments, comme les stimulants, peuvent augmenter le risque d'arythmies."
}
}
]
}
]
}
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
Pulmonary Arterial Hypertension (PAH) is a clinical syndrome consisting of physiologic/hemodynamic criteria that are a consequence of several etiologies. Systemic Sclerosis (SSc), one of the most comm...
Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort....
Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?...
We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II...
In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529...
The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...
Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with...
Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi...
Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0...
Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc...
We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul...
The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv...
SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...
Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare...
A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab...
A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo...
Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....
Systemic sclerosis (SSc), also known as scleroderma, is a chronic autoimmune connective tissue disease and is associated with a significant economic burden resulting from health care utilization costs...